JPH09506435A - アレルギー診断法および抗アレルギー性治療剤のスクリーニング法 - Google Patents
アレルギー診断法および抗アレルギー性治療剤のスクリーニング法Info
- Publication number
- JPH09506435A JPH09506435A JP7516387A JP51638795A JPH09506435A JP H09506435 A JPH09506435 A JP H09506435A JP 7516387 A JP7516387 A JP 7516387A JP 51638795 A JP51638795 A JP 51638795A JP H09506435 A JPH09506435 A JP H09506435A
- Authority
- JP
- Japan
- Prior art keywords
- ige
- release
- cells
- allergen
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.患者におけるアレルギー性疾患の診断法であって、 (a)放出混合物中への薬理学的伝達物質放出を遮断放出混合物中への薬理学 的伝達物質放出と比較すること、ただしここに、放出混合物および遮断放出混合 物はおのおのナイーブ提供者からの単一組織標本の一部を含み、およびここに、 放出混合物および遮断放出混合物はおのおのさらに、血液標本中の目的アレルゲ ンに特異的なIgEの存在または不在が未知な、患者からの単一血液標本の一部 を含み、およびここに、遮断放出混合物はさらにIgE拮抗剤を含み、およびこ こに、放出混合物および遮断放出混合物双方をアレルゲンと混合するものとする 、 (b)段階(a)での比較に基づいて、その血清標本中にそのアレルゲンに特 異的なIgEの存在または不在を決定すること を含む診断法。 2.薬理学的伝達物質がヒスタミンである請求項1の方法。 3.組織標本が血液標本である請求項1の方法。 4.IgE拮抗剤が抗IgE抗体またはその断片である請求項1の方法。 5.抗IgE抗体がモノクローナル抗IgE抗体である請求項4の方法。 6.モノクローナル抗IgE抗体がrhuMAbE25である請求項5の方法。 7.IgE拮抗剤がIgE変異体またはその断片である請求項1の方法。 8.IgE拮抗剤が可溶性FcεRI受容体である請求項1の方法。 9.IgE拮抗剤がIgE結合性ペプチドまたはFcεRI受容体結合性ペプチ ドである請求項1の方法。 10.遮断放出混合物中の組織標本を最初にIgE拮抗剤と混合し、次に患者か らの血清標本と混合する請求項1の方法。 11.遮断放出混合物中の血清標本を最初にIgE拮抗剤と混合し、次に組織標 本と混合する請求項1の方法。 12.好塩基球のIgE誘導感化を遮断する薬剤の生物活性検定法であって、 (a)放出混合物中への薬理学的伝達物質放出を遮断放出混合物中への薬理学 的伝達物質放出と比較すること、ただしここに、放出混合物および遮断放出混合 物はおのおのナイーブ提供者から得た単一全血標本の一部を含み、およびここに 、放出混合物および遮断放出混合物はおのおのさらにアレルゲンに特異的なIg Eを含む単一血清標本の一部を含み、およびここに、遮断放出混合物はさらに薬 剤を含み、およびここに、放出混合物および遮断放出混合物双方をアレルゲンと 混合するものとする、 (b)段階(a)での比較に基づいて、好塩基球のIgE誘導感化を遮断する 薬剤の生物活性を決定すること を含む薬剤の生物活性検定法。 13.薬剤が抗アレルギー性治療剤候補である請求項12の方法。 14.抗アレルギー性治療剤候補が抗IgE抗体またはその断片、IgE変異体 またはその断片、可溶性FcεRI受容体、IgE結合性ペプチドおよびFcε RI受容体結合性ペプチドから構成される群から選択される請求項13の方法。 15.薬剤がIgE拮抗剤候補である請求項12の方法。 16.IgE拮抗剤候補が抗IgE抗体またはその断片、IgE変異体またはそ の断片、可溶性FcεRI受容体、IgE結合性ペプチドおよびFcεRI受容 体結合性ペプチドから構成される群から選択される請求項15の方法。 17.遮断放出混合物中の全血標本を最初に薬剤と混合し、次に血清標本と混合 する請求項12の方法。 18.遮断放出混合物中の血清標本を最初に薬剤と混合し、次に全血標本と混合 する請求項12の方法。 19.患者におけるアレルギー性疾患の診断法であって、 (a)反応混合物中への薬理学的伝達物質放出を遮断反応混合物中への薬理学 的伝達物質放出と比較すること、ただしここに、 (1)反応混合物および遮断反応混合物は患者血清IgEおよびアレルゲンに よる誘導に際して宿主細胞の薬理学的伝達物質放出を媒介することのできるFcε RIαサブユニットの表面発現を示すように遺伝子工学的に処理した肥満細胞 宿主のいずれか、および患者血清IgEおよびアレルゲンによる誘導に際して宿 主細胞の薬理学的伝達物質放出を媒介することのできるFcεRIαサブユニッ トの表面発現を示すように遺伝子工学的に処理した好塩基球細胞宿主のいずれか から構成される群から選択した共通の親細胞の子孫である遺伝子工学的に処理し た細胞を含み、 (2)反応混合物および遮断反応混合物はおのおのさらに血清標本中の目的ア レルゲンに特異的なIgEの存在または不在が未知な、患者からの単一血清標本 の一部を含み、 (3)遮断反応混合物はさらにIgE拮抗剤を含み、および (4)放出混合物および遮断放出混合物双方をアレルゲンとを混合するものと する、 (b)段階(a)での比較に基づいて、その血清標本中にそのアレルゲンに特 異的なIgEの存在または不在を決定すること を含む診断法。 20.遺伝子工学的に処理した細胞が遺伝子工学的に処理した肥満細胞である請 求項19の方法。 21.遺伝子工学的に処理した肥満細胞が遺伝子工学的に処理した齧歯類肥満細 胞である請求項20の方法。 22.遺伝子工学的に処理した齧歯類肥満細胞が遺伝子工学的に処理したラット 肥満細胞である請求項21の方法。 23.遺伝子工学的に処理したラット肥満細胞がRBL48細胞である請求項2 2の方法。 24.FcεRIαサブユニットが患者の動物種から誘導される請求項19の方 法。 25.患者がヒトである請求項19の方法。 26.FcεRIαサブユニットをヒト起源から誘導する請求項19の方法。 27.FcεRIαサブユニットが遺伝子工学的に処理した細胞に対して外因性 である請求項19の方法。 28.IgE拮抗剤が抗IgE抗体またはその断片である請求項19の方法。 29.抗IgE抗体がモノクローナル抗IgE抗体である請求項28の方法。 30.抗IgE抗体がrhuMAbE25である請求項29の方法。 31.IgE拮抗剤がIgE変異体またはその断片である請求項19の方法。 32.IgE拮抗剤が可溶性FcεRI受容体である請求項19の方法。 33.IgE拮抗剤がIgE結合性ペプチドまたはFcεRI受容体結合性ペプ チドである請求項19の方法。 34.遮断反応混合物中の遺伝子工学的に処理した細胞を最初にIgE拮抗剤と 混合し、次に患者からの血清標本と混合する請求項19の方法。 35.遮断反応混合物中の血清標本を最初にIgE拮抗剤と混合し、次に遺伝子 工学的に処理した細胞と混合する請求項19の方法。 36.薬理学的伝達物質がヒスタミンである請求項19の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16543693A | 1993-12-10 | 1993-12-10 | |
US08/165,436 | 1993-12-10 | ||
PCT/US1994/014282 WO1995016203A2 (en) | 1993-12-10 | 1994-12-09 | Methods for diagnosis of allergy and screening of anti-allergy therapeutics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09506435A true JPH09506435A (ja) | 1997-06-24 |
JP3507852B2 JP3507852B2 (ja) | 2004-03-15 |
Family
ID=22598886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51638795A Expired - Lifetime JP3507852B2 (ja) | 1993-12-10 | 1994-12-09 | アレルギー診断法および抗アレルギー性治療剤のスクリーニング法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US5714338A (ja) |
EP (1) | EP0733207B1 (ja) |
JP (1) | JP3507852B2 (ja) |
AT (1) | ATE157455T1 (ja) |
CA (1) | CA2176811C (ja) |
DE (1) | DE69405251T2 (ja) |
DK (1) | DK0733207T3 (ja) |
ES (1) | ES2108566T3 (ja) |
GR (1) | GR3025089T3 (ja) |
WO (1) | WO1995016203A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010511154A (ja) * | 2006-12-01 | 2010-04-08 | スタテンス セールム インスティトゥート | 濾紙上のサンプル吸着を用いたスクリーニング方法 |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9526599D0 (en) * | 1995-12-28 | 1996-02-28 | Sandoz Ltd | Elisa test system |
DE19643427C1 (de) * | 1996-10-22 | 1998-02-12 | Bundesrep Deutschland | Verfahren zur Bestimmung von Allergenen in der Luft |
US6165799A (en) * | 1996-12-10 | 2000-12-26 | Heska Corporation | Detection of anti-Fc.sub.ε R autoantibodies in asthmatics |
US7122636B1 (en) | 1997-02-21 | 2006-10-17 | Genentech, Inc. | Antibody fragment-polymer conjugates and uses of same |
US6060326A (en) * | 1997-04-07 | 2000-05-09 | Heska Corporation | Method to detect canine IgE and kit therefor |
FR2765341A1 (fr) * | 1997-06-25 | 1998-12-31 | Alain Funes | Methode pour l'analyse de l'activation des basophiles humains par mesure de l'expression membranaire du marqueur cd63 |
WO2000029431A1 (en) * | 1998-11-17 | 2000-05-25 | Tanox, Inc. | Bispecific molecules cross-linking itim and itam for therapy |
WO2001051076A1 (en) * | 2000-01-14 | 2001-07-19 | Tanox, Inc. | ADMINISTERING IgE ANTAGONISTS DURING PREGNANCY TO AMELIORATE ALLERGIC DISEASES IN THE OFFSPRING |
US6889145B1 (en) | 2000-03-15 | 2005-05-03 | Northwestern University | Three-dimensional model of a Fc region of an IgE antibody and uses thereof |
EP1195606A1 (en) * | 2000-10-03 | 2002-04-10 | VBC-Genomics Forschungsges.m.b.H. | Allergen-microarray assay |
DE10110838C2 (de) * | 2001-03-06 | 2003-04-03 | Mlu Halle Wittenberg | Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen |
FR2831186B1 (fr) * | 2001-10-22 | 2004-06-18 | Aventis Pharma Sa | Production d'heparine a partir de cultures de mastocytes |
EP2048154B2 (en) | 2002-02-05 | 2015-06-03 | Genentech, Inc. | Protein purification |
AU2003265235A1 (en) | 2002-04-26 | 2003-12-19 | Genetech, Inc. | Non-affinity purification of proteins |
DK3095793T3 (da) | 2003-07-28 | 2020-05-25 | Genentech Inc | Reducering af udvaskning af protein A under en protein A-affinitetskromatografi |
US7613619B1 (en) * | 2004-03-30 | 2009-11-03 | Harter Michael R | Method for identifying allergens and other influencing agents that may cause a reaction |
US7655229B2 (en) * | 2004-09-02 | 2010-02-02 | Chan Andrew C | Anti-FC-gamma RIIB receptor antibody and uses therefor |
AU2005282720B2 (en) * | 2004-09-02 | 2011-08-04 | Genentech, Inc. | Anti-FC-gamma RIIB receptor antibody and uses therefor |
US7662926B2 (en) * | 2004-09-02 | 2010-02-16 | Genentech, Inc. | Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor |
JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
DE602005027493D1 (de) * | 2005-03-16 | 2011-05-26 | Nutricia Nv | Verfahren zur bestimmung einer allergischen reaktion |
JP2009509124A (ja) * | 2005-06-16 | 2009-03-05 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 大型のパラレルの免疫ベースのアレルギー試験および蛍光のエバネセント場励起のためのデバイス |
US20080011058A1 (en) * | 2006-03-20 | 2008-01-17 | The Regents Of The University Of California | Piezoresistive cantilever based nanoflow and viscosity sensor for microchannels |
FR2902799B1 (fr) | 2006-06-27 | 2012-10-26 | Millipore Corp | Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide |
US8569464B2 (en) | 2006-12-21 | 2013-10-29 | Emd Millipore Corporation | Purification of proteins |
US8362217B2 (en) | 2006-12-21 | 2013-01-29 | Emd Millipore Corporation | Purification of proteins |
WO2008079302A2 (en) | 2006-12-21 | 2008-07-03 | Millipore Corporation | Purification of proteins |
NZ577933A (en) | 2007-01-22 | 2011-12-22 | Genentech Inc | Polyelectrolyte precipitation and purification of antibodies |
US8191403B2 (en) * | 2007-03-27 | 2012-06-05 | Richmond Chemical Corporation | Petroleum viscosity measurement and communication system and method |
KR20190140090A (ko) | 2007-07-09 | 2019-12-18 | 제넨테크, 인크. | 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지 |
RU2498991C2 (ru) | 2007-10-30 | 2013-11-20 | Дженентек, Инк. | Очистка антител с помощью катионообменной хроматографии |
WO2009151514A1 (en) * | 2008-06-11 | 2009-12-17 | Millipore Corporation | Stirred tank bioreactor |
EP3604324B1 (en) | 2008-08-14 | 2024-02-28 | Genentech, Inc. | Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography |
EP2684570A1 (en) | 2008-09-10 | 2014-01-15 | F. Hoffmann-La Roche AG | Compositions and methods for the prevention of oxidative degradation of proteins |
WO2010074702A1 (en) | 2008-12-16 | 2010-07-01 | Millipore Corporation | Purification of proteins |
SG171446A1 (en) | 2008-12-16 | 2011-07-28 | Millipore Corp | Stirred tank reactor and method |
EP2400992B1 (en) | 2009-02-27 | 2015-07-22 | Genentech, Inc. | Methods and compositions for protein labelling |
WO2010114912A1 (en) * | 2009-03-31 | 2010-10-07 | University Of North Carolina At Greensboro | Minimally invasive assessment of ige mediated allergy |
DE102009030845A1 (de) * | 2009-06-26 | 2010-12-30 | Siemens Aktiengesellschaft | Verfahren und Kit zur Diagnose oder Prognose einer Kontrastmittelallergie |
SG10201901417UA (en) | 2009-08-11 | 2019-03-28 | Genentech Inc | Production of proteins in glutamine-free cell culture media |
KR101764449B1 (ko) | 2009-09-01 | 2017-08-02 | 제넨테크, 인크. | 변형된 단백질 a 용리를 통한 증진된 단백질 정제 |
CA2792125C (en) | 2010-03-22 | 2019-02-12 | Genentech, Inc. | Compositions and methods useful for stabilizing protein-containing formulations |
MX2012012743A (es) | 2010-05-03 | 2012-11-23 | Genentech Inc | Composiciones y metodos utiles para reducir la viscosidad de formulaciones que contienen proteina. |
CN102892791B (zh) | 2010-05-17 | 2017-05-17 | Emd密理博公司 | 用于纯化生物分子的刺激响应性聚合物 |
RU2614125C2 (ru) | 2010-05-28 | 2017-03-22 | Дженентек, Инк. | Снижение уровня лактата и увеличение продукции полипептида путем ингибирования экспрессии лактатдегидрогеназы и киназы пируватдегидрогеназы |
SG186783A1 (en) | 2010-06-24 | 2013-02-28 | Genentech Inc | Compositions and methods containing alkylgycosides for stabilizing protein- containing formulations |
CA2808185A1 (en) | 2010-08-13 | 2012-02-16 | Genentech, Inc. | Antibodies to il-1.beta. and il-18, for treatment of disease |
WO2012030512A1 (en) | 2010-09-03 | 2012-03-08 | Percivia Llc. | Flow-through protein purification process |
KR101949187B1 (ko) | 2011-07-08 | 2019-04-22 | 이엠디 밀리포어 코포레이션 | 일회용 생명공학적 공정용의 개선된 심층 필터 |
TR201815709T4 (tr) | 2011-12-22 | 2018-11-21 | Hoffmann La Roche | İyon değişim membranı kromatografisi. |
EP2831261B1 (en) | 2012-03-27 | 2017-10-18 | F. Hoffmann-La Roche AG | Method for producing recombinant proteins with low levels of DHNA (1,4-dihydroxy-2-naphthoate) |
SG10201709555SA (en) | 2012-05-18 | 2017-12-28 | Genentech Inc | High-concentration monoclonal antibody formulations |
CN104994885B (zh) | 2012-12-19 | 2017-09-29 | 基因泰克公司 | 用于放射性卤素蛋白质标记的方法和组合物 |
BR112017000142B1 (pt) | 2014-07-09 | 2021-08-17 | Genentech, Inc | Métodos para melhorar a recuperação por descongelamento de bancos de células e para congelamento de células cho para armazenamento, grupo de células cho para o congelamento de células de mamíferos, e banco de células |
MX2018011834A (es) | 2016-03-29 | 2019-03-06 | Geltor Inc | Expresión de proteínas en bacterias gram negativas en la que la relación del volumen periplasmático con respecto al volumen citoplasmático está entre 0.5:1 y 10:1. |
JP2020503316A (ja) | 2016-12-22 | 2020-01-30 | ジェネンテック, インコーポレイテッド | 凍結乾燥ポリペプチドの再構成時間を低減するための方法及び製剤 |
US11180541B2 (en) | 2017-09-28 | 2021-11-23 | Geltor, Inc. | Recombinant collagen and elastin molecules and uses thereof |
CA3104684A1 (en) | 2018-07-03 | 2020-01-09 | Bristol-Myers Squibb Company | Methods of producing recombinant proteins |
KR20210074341A (ko) | 2018-10-10 | 2021-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 고밀도 생물 반응기 배양에서 막 기체 전달을 위한 방법 |
CA3133652A1 (en) | 2019-04-01 | 2020-10-08 | Genentech, Inc. | Compositions and methods for stabilizing protein-containing formulations |
CN113993885A (zh) | 2019-04-12 | 2022-01-28 | 格尔托公司 | 重组弹性蛋白及其生产 |
KR20220039777A (ko) | 2019-08-01 | 2022-03-29 | 브리스톨-마이어스 스큅 컴퍼니 | 유가식 세포 배양에서 단백질 생산성을 개선시키는 방법 |
JP2023542924A (ja) | 2020-09-22 | 2023-10-12 | ブリストル-マイヤーズ スクイブ カンパニー | 治療タンパク質を生産するための方法 |
CN113495139A (zh) * | 2021-07-07 | 2021-10-12 | 上海清芮科技有限公司 | 一种宠物特应性体质的检测方法 |
WO2023015234A1 (en) | 2021-08-05 | 2023-02-09 | Bristol-Myers Squibb Company | Cell culture methods for producing therapeutic proteins |
WO2023049687A1 (en) | 2021-09-21 | 2023-03-30 | Bristol-Myers Squibb Company | Methods of controlling the level of dissolved oxygen (do) in a solution comprising a recombinant protein in a storage container |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4559310A (en) * | 1983-05-20 | 1985-12-17 | Dana Farber Cancer Institute | Assay methods and systems utilizing mast cell clones |
US4946788A (en) * | 1985-06-11 | 1990-08-07 | Ciba-Geigy Corporation | Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications |
EP0248211B1 (en) * | 1986-04-30 | 1992-03-11 | Junji Yodoi | Novel protein and a method for production thereof |
US5180805A (en) * | 1986-07-02 | 1993-01-19 | Research Corporation Limited | Polypeptide competitor for immunoglobulin E |
GB8727045D0 (en) * | 1987-11-19 | 1987-12-23 | Research Corp Ltd | Immunoglobulin e competitor |
US4962035A (en) * | 1987-12-01 | 1990-10-09 | President And Fellows Of Harvard College | DNA encoding IgE receptor alpha-subunit or fragment thereof |
JPH03127997A (ja) * | 1989-10-11 | 1991-05-31 | Kuraray Co Ltd | ヒト1gE結合因子に特異的なモノクローン抗体、それを産生するハイブリドーマおよびその用途 |
CA2059842A1 (en) * | 1991-02-11 | 1992-08-12 | Richard A. Chizzonite | Ige-receptor-antibodies |
AU2917992A (en) * | 1991-12-05 | 1993-06-28 | Board Of Regents Of The University Of Nebraska, The | Allergen specific immunoglobulin-e producer test for diagnosing allergies |
GB9224956D0 (en) * | 1992-11-28 | 1993-01-20 | Euro Dpc Ltd | Improvements relating to allergen testing & apparatus |
-
1994
- 1994-12-09 US US08/393,014 patent/US5714338A/en not_active Expired - Lifetime
- 1994-12-09 ES ES95905357T patent/ES2108566T3/es not_active Expired - Lifetime
- 1994-12-09 CA CA002176811A patent/CA2176811C/en not_active Expired - Lifetime
- 1994-12-09 WO PCT/US1994/014282 patent/WO1995016203A2/en active IP Right Grant
- 1994-12-09 AT AT95905357T patent/ATE157455T1/de active
- 1994-12-09 DE DE69405251T patent/DE69405251T2/de not_active Expired - Lifetime
- 1994-12-09 EP EP95905357A patent/EP0733207B1/en not_active Expired - Lifetime
- 1994-12-09 JP JP51638795A patent/JP3507852B2/ja not_active Expired - Lifetime
- 1994-12-09 DK DK95905357.0T patent/DK0733207T3/da active
-
1997
- 1997-10-20 GR GR970402730T patent/GR3025089T3/el unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010511154A (ja) * | 2006-12-01 | 2010-04-08 | スタテンス セールム インスティトゥート | 濾紙上のサンプル吸着を用いたスクリーニング方法 |
Also Published As
Publication number | Publication date |
---|---|
ATE157455T1 (de) | 1997-09-15 |
DE69405251T2 (de) | 1998-02-05 |
CA2176811C (en) | 2008-01-29 |
WO1995016203A3 (en) | 1995-06-29 |
DK0733207T3 (da) | 1998-04-20 |
DE69405251D1 (de) | 1997-10-02 |
WO1995016203A2 (en) | 1995-06-15 |
EP0733207B1 (en) | 1997-08-27 |
EP0733207A1 (en) | 1996-09-25 |
ES2108566T3 (es) | 1997-12-16 |
JP3507852B2 (ja) | 2004-03-15 |
CA2176811A1 (en) | 1995-06-15 |
GR3025089T3 (en) | 1998-01-30 |
US5714338A (en) | 1998-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09506435A (ja) | アレルギー診断法および抗アレルギー性治療剤のスクリーニング法 | |
CN110249226B (zh) | 评估患者样品中gfap状态的改进方法 | |
Sihra et al. | Expression of high-affinity IgE receptors (FcϵRI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: Relationship to total serum IgE concentrations | |
AU617980B2 (en) | Cell-free t cell antigen receptor and its clinical utilities | |
JP6139885B2 (ja) | 治療的抗IgE抗体に特異的な抗体を検出するためのアッセイ及びアナフィラキシーにおけるそれらの使用 | |
US6998241B2 (en) | Antibody pair screening methods | |
US20210382064A1 (en) | Generation of human allergen- and helminth-specific ige monoclonal antibodies for diagnostic and therapeutic use | |
Chirumbolo et al. | Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study | |
Torrero et al. | CD200R surface expression as a marker of murine basophil activation | |
Hamilton | Accuracy of US Food and Drug Administration–cleared IgE antibody assays in the presence of anti-IgE (omalizumab) | |
EP2150819B1 (en) | S100a9 interaction screening method | |
WO2013107826A2 (en) | Use of cellular biomarkers expression to diagnose sepsis among intensive care patients | |
US20150065374A1 (en) | Detection of Platelet-Derived Shed CD31 | |
WO2024026384A1 (en) | Assays for detection and quantitation of human endotrophin | |
US20130183248A1 (en) | Method and kit for detection of autoimmune chronic urticaria | |
WO2006124866A2 (en) | Free human serum ige immunoenzymetric assay and methods of use | |
WO2003025566A2 (en) | A method and kit for the measurement of the activation of basophils induced by allergen to determine hypersensitivity | |
Egli et al. | Evaluation of the usefulness of sensitization to aeroallergens as a model for canine atopic dermatitis in genetically predisposed Beagles | |
US20050003461A1 (en) | Method for detecting allergies | |
Grammer et al. | Immunological evaluation of occupational asthma | |
EP1991868B1 (en) | Method to determine pseudo-allergic reactions | |
WO2000052472A1 (en) | Rapid assay for infection in small children | |
US20240230665A9 (en) | Generation of human allergen- and helminth-specific ige monoclonal antibodies for diagnostic and therapeutic use | |
CA2996299C (en) | Methods and compositions for the detection of fc receptor binding activity of antibodies | |
JP3268494B2 (ja) | 全身性エリテマトーデス病態診断剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080109 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090109 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090109 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100109 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110109 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110109 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120109 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130109 Year of fee payment: 9 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |